Mary Wu

The Francis Crick Institute — United Kingdom

Medicine · Health Sciences

37h-index6.3kcitations134works5.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(62), COVID-19 Clinical Research Studies(35), SARS-CoV-2 detection and testing(16), RNA modifications and cancer(13), Epigenetics and DNA Methylation(12)

Publications119 total

Third exposure to COVID-19 infection or vaccination differentially impacts T cell responses
Journal of Infection·2025Open Access
Author Reply to Peer Reviews of SARS-CoV-2 envelope protein induces LC3 lipidation via the V-ATPase-ATG16L1 axis
2025
Improved Resolution of Influenza Vaccination Responses With High‐Throughput Live Virus Microneutralisation
Influenza and Other Respiratory Viruses·2025Open Access
SARS-CoV-2 antibody immunity across three continents: the West Africa, West Indies, West London Consortium
2025Open Access
SARS-CoV-2 envelope protein induces LC3 lipidation via the V-ATPase-ATG16L1 axis
2025Open Access
Impact of first SARS-CoV-2 infection variant on serological responses against Omicron: findings from the SIREN study
2025Open Access
Investigation of Influenza A(H5N1) Virus Neutralization by Quadrivalent Seasonal Vaccines, United Kingdom, 2021–2024
Emerging infectious diseases·2025· 4 citedOpen Access
Adults in Ghana generate higher and more durable neutralising antibody titres following primary course COVID-19 vaccination than matched UK adults: The HERITAGE Study
BMC Medicine·2025· 2 citedOpen Access
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics
Vaccine·2025Open Access
15 Divergent performance of bivalent BA.5 and monovalent XBB.1.5 COVID-19 vaccines given as annual booster
Clinical Infection in Practice·2025Open Access
24 B cell depletion therapy in people with Multiple Sclerosis impacts on antibody response to COVID-19 mRNA vaccines
Clinical Infection in Practice·2025Open Access
Improved resolution of influenza vaccination responses with high-throughput live virus microneutralisation
2024· 1 citedOpen Access
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study
The Lancet Infectious Diseases·2024· 6 citedOpen Access
De novo design of high-affinity protein binders with AlphaProteo
arXiv (Cornell University)·2024· 42 citedOpen Access
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial
The Lancet Rheumatology·2024· 26 citedOpen Access
Accurate evaluation of live-virus microneutralization for SARS-CoV-2 variant JN.1
2024Open Access
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign
The Lancet·2024· 10 citedOpen Access
Optimizing warfarin dosing for patients with atrial fibrillation using machine learning
Scientific Reports·2024· 19 citedOpen Access
Accurate Evaluation of Live-Virus Microneutralization for SARS-CoV-2 Variant JN.1 in the Assessment of Vaccination and Therapeutics
SSRN Electronic Journal·2024Open Access
Chronogram: an R package for data curation and analysis of infection and vaccination cohort studies
Bioinformatics Advances·2024· 3 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Rupert Beale(32), Michael Howell(31), Charles Swanton(22), Sonia Gandhi(21), Ruth Harvey(20), George Kassiotis(18), David L.V. Bauer(15), Edward J Carr(13), Emma Wall(12), Svend Kjær(12), Simon Caidan(11), Gavin Kelly(10), Steve Gamblin(10), James I. MacRae(10), Rachel Ulferts(10), Nicola O’Reilly(9), Scott Warchal(8), Karen Ambrose(8), Samra Turajlic(8), Saira Hussain(7)